Managing Glaucoma Eye Drop Side Effects

The Hidden Cost of “Silent” Protection is Managing Glaucoma Eye Drop Side Effects. For most patients, glaucoma treatment begins with…

What Eye Pressure Is Dangerous?

Patients often ask what Eye Pressure Is Dangerous. Understanding Eye Pressure and Glaucoma Risk is important. Many patients are told…

Dr Shibal Bhartiya- Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya — Glaucoma Specialist in Gurgaon

Glaucoma surgery

Dr. Shibal Bhartiya: Expert Glaucoma Specialist & Clinician-Scientist

Dr. Shibal Bhartiya is a globally recognized authority in Glaucoma and Neuro-Ophthalmology, currently serving as the Clinical Director at Marengo Asia Hospitals, Gurgaon. She is also a Research Collaborator with Mayo Clinic, Jacksonville, USA. Former Senior Scientific Research Fellow (Glaucoma)  University of Geneva, Switzerland & Former Senior Research Associate (Glaucoma + Cornea), AIIMS, New Delhi. 

With over 27 years of experience, she is one of the few specialists in India who seamlessly bridges the gap between high-volume clinical excellence and international medical research.

At a Glance

🎓 Fellowship trained — University of Geneva, Switzerland & AIIMS New Delhi
🔬 Research Collaborator — Mayo Clinic, Jacksonville, USA 
📚 200+ peer-reviewed publications · 20+ edited textbooks on glaucoma
🏆 Best Research Paper Awards — Asia Pacific Academy of Ophthalmology, Asia Pacific Glaucoma Congress, International Society of Glaucoma Surgery
🏥 Clinical Director, Ophthalmology — Marengo Asia Hospitals, Gurgaon

Academic & Research Distinction

As a Research Collaborator with the Mayo Clinic (Jacksonville, USA), Dr. Bhartiya is at the forefront of global innovations in eye care. Her academic journey includes a prestigious Clinical Research Fellowship in Glaucoma from the University of Geneva, Switzerland, and extensive training at AIIMS, New Delhi.

She is a prolific author of 28 medical textbooks and has published over 200 peer-reviewed research papers in international journals. Her leadership in the field is further cemented as the Executive Editor of the Journal of Current Glaucoma Practice and her role on the Associate Advisory Committee of the International Society of Glaucoma Surgery (ISGS).

Her work can be accessed on Pubmed, Google Scholar, ResearchGate and ORCID.

Patient-Centric Excellence

Beyond her academic accolades, Dr. Bhartiya is arguably the most trusted glaucoma specialist in Gurgaon, maintaining a perfect 5.0-star rating across 1,500+ verified patient reviews. She is widely sought after for ethical glaucoma care and second opinions, specializing in:

  • Evidence-Based, Non-Surgical Protocols
  • Complex Glaucoma Management (Medical & Surgical)
  • Neuro-Ophthalmology & Ocular Surface Diseases
  • Minimally Invasive Glaucoma Surgery (MIGS)

Focus Areas: Providing advanced diagnosis, glaucoma treatment, risk stratification, and second opinions for glaucoma and optic nerve disease. Long-term vision protection.

The Ethical Care Philosophy

Dr. Bhartiya is known for her “patient-first” approach, focusing on long-term vision preservation rather than unnecessary surgical intervention. Her practice is built on transparency, humane care, and the same rigorous standards found at the world’s leading eye institutes.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist  in Gurgaon, currently serving as Clinical Director of Ophthalmology at Marengo Asia Hospitals, Sector 56, Gurugram, and as Research Collaborator at Mayo Clinic, Jacksonville, Florida, USA.

Her clinical focus is glaucoma across its full spectrum- from early detection and borderline disease to complex surgery and second opinions for patients who need clarity on a difficult diagnosis. She also sees patients with neuro-ophthalmological conditions and ocular surface disease.

Dr Bhartiya trained at AIIMS New Delhi, completed a Clinical Research Fellowship in Glaucoma at the University of Geneva, Switzerland, and is currently enrolled for a Doctorate en Médecin at the University of Geneva. Over two decades of glaucoma specialty practice, international research collaboration, and editorial leadership in glaucoma have shaped an approach to care that is careful, long-term, and built around protecting vision, and not just treating numbers.

What I Treat

My practice is focused on patients with glaucoma at every stage — from those who have just been told they may be a glaucoma suspect, to those managing advanced disease after failed surgery. I also see a significant number of patients who come for a structured second opinion, from Gurgaon, NCT and all over India, often after an unclear diagnosis or conflicting advice from different doctors.

Conditions I see regularly: — Primary open-angle glaucoma and normal tension glaucoma — Angle closure glaucoma and angle closure suspects — Ocular hypertension and glaucoma suspects — Secondary glaucomas: steroid-induced, post-uveitic, post-traumatic, after retinal surgery or corneal transplant  Neovascular and complex refractory glaucoma

 Neuro-ophthalmological conditions: optic neuropathy, unexplained visual field loss, optic neuritis, papilledema — Ocular surface disease and dry eye in the context of glaucoma treatment

If you are unsure whether your situation fits, the contact page has details for reaching my coordinator directly. You can also reach me through the Marengo Asia Hospitals appointment page here

Training and Qualifications

Fellowship Training

Clinical Research Fellowship in Glaucoma, Clinique d’Ophtalmologie, Department of Clinical Neurosciences, Hôpitaux Universitaires de Genève, University of Geneva, Switzerland (2010–11).

Also enrolled: Doctorat en Médecin, University of Geneva.

Senior Clinical Research Associate, Cornea and Glaucoma Services, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi (2007–10).

MS Ophthalmology, Maulana Azad Medical College, New Delhi (2007–10).

Current Positions

Clinical Director, Ophthalmology, Marengo Asia Hospitals, Gurugram (July 2024 to date) Program

Director, Community Outreach & Wellness,  Marengo Asia Hospitals, Gurugram and Faridabad

Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)

Research Collaborator, Mayo Clinic, Jacksonville, Florida, USA (September 2024 to date)

Academic and Editorial Leadership

Dr Bhartiya holds editorial positions at three international peer-reviewed journals:

 Editor-in-Chief, Clinical and Experimental Vision and Eye Research 

Editor-in-Chief, Ocular Research Journal

Executive Editor, Journal of Current Glaucoma Practice

She is a Member of the Associate Advisory Committee, International Society of Glaucoma Surgery, and serves on the Delhi Ophthalmic Society International Advisory Sub-Committee.

She has edited more than 20 textbooks in glaucoma and ophthalmology, and contributed chapters to more than 20 others. Her peer-reviewed research is indexed on PubMed and Google Scholar.

Awards and Recognition

Best Paper, Glaucoma Session — APAO, Hyderabad (Continuous IOP Monitoring in Glaucoma)

Best Paper, Glaucoma Session and Top Nine Most Influential Papers — Asia Pacific Glaucoma Congress, Bali 2012 (Diurnal IOP Fluctuation in Angle Closure)

 Multiple best paper recognitions at International Society for Glaucoma Surgery congresses

Global Outreach and Community Work

Beyond clinical practice, Dr Bhartiya has led glaucoma screening and surgical programmes in underserved communities across three continents.

In Egypt, she led a humanitarian mission to Kom Ombo General Hospital, Aswan, conducting screening for over 5,000 patients including children, and provided both medical and surgical management of advanced glaucomas in North Africa. She has also delivered skill-transfer sessions in advanced glaucoma care for doctors, residents, and optometrists in Aswan.

In Switzerland, she designed and executed hospital-based and community glaucoma screening protocols in Geneva and Troinnex, and led screening of United Nations personnel as part of World Glaucoma Week.

In India, she is an active contributor to the Motiabind Mukti Abhiyan cataract outreach programme, has led eye camps in Sirsa (Haryana), and runs school health initiatives and government employee screening programmes in Gurugram.

She is also the founder of Vision Unlimited, a not-for-profit organisation currently running six learning centres in urban Gurugram, serving over 1,200 children with education, nutrition, and healthcare support.

As part of the Eye on the Future program, Vision Unlimited under the guidance of Dr Bhartiya has screened more than 15000 school children; and 5000 elders from underserved areas for refractive errors, and other ocular morbidities. 

Research

Active clinical research collaborations span glaucoma medication adherence, quality of life, IOP monitoring, community-based screening, and surgical outcomes. Dr Bhartiya collaborates with glaucoma specialists across more than 20 countries.

Current trials include work on 24-hour ambulatory IOP monitoring, selective laser trabeculoplasty as primary therapy, tear film osmolarity in glaucoma patients, and quantitative versus qualitative IOP control, as well as metabolic determinants of glaucoma.

Full publication list: PubMed · Google Scholar · Publications page

Book an Appointment

For appointments at Marengo Asia Hospitals, Sector 56, Gurugram, please contact my coordinator at +91 88826 38735.

If you are seeking a structured glaucoma second opinion, you may also use the second opinion form to submit your reports in advance of your consultation.

As a fellowship-trained glaucoma specialist (from University of Geneva, Switzerland, and AIIMS, New Delhi) in Gurgaon, Dr Shibal Bhartiya works with patients across the full spectrum of glaucoma—from suspects and early disease to advanced and complex cases. Her approach emphasises risk stratification, longitudinal follow-up, and calm decision-making, helping patients avoid late surprises and unnecessary interventions.

Patients often seek her care for early glaucoma diagnosis, second opinions, treatment planning, and long-term glaucoma management (medical, glaucoma lasers and glaucoma surgery including MIGS, trabeculectomy and complex tubes and shunts), especially when clarity is needed in uncertain, complex, or borderline cases.

Academic Qualifications:

  • 2010-11 – Clinical Research Fellowship, Glaucoma, University of Geneva, Switzerland
  • 2007-10 – MS (Ophthalmology), Maulana Azad Medical College, New Delhi, India
    1993-99 – M.B.B.S, Maulana Azad Medical College, New Delhi
  • 2000-03 – Clinical Research Associateship, Cornea and Glaucoma, Dr R P Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Doctorate en Medicin, University of Geneva, Switzerland (Currently enrolled)

Experience details:

  • July 2024 to date- Clinical Director, Ophthalmology (MAH, Gurgaon); Program Director, Community Outreach & Wellness (MAH, Gurgaon and Faridabad)
    Program Director, Marengo Asia International Institute of Neuro & Spine (Pan-India)
  • Sept 2024 to date– Research collaborator, Mayo Clinic, Jacksonville, USA
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2012-July 2024- Director, Additional Director, Sr. Consultant, Consultant – Ophthalmology, Fortis Memorial Research Institute, India

Additional Role

  • Sept 2024 – till date- Research collaborator, Mayo Clinic, Jacksonville, USA
  • August 2015-October 2015- Consultant, Cantahealth, Healthcare Practice, Eliglobal, Charlotte, North Carolina, USA. (Training and development of AI platforms and interfaces in Ophthalmology)
  • Oct 2015- April 2017- Clinical Director, Medflow, Eye Care Leaders (Eliglobal), Charlotte, North Carolina, USA. (Training and development of AI platforms and CDSS interfaces in Ophthalmology)
  • Sept 2012 to Aug 2015 – Consultant, Glaucoma and Preventive Health Services, Department of Ophthalmology, Fortis Memorial Research Institute, Gurgaon, Haryana
  • Sept 2011 to Aug 2012 – Consultant Glaucoma and In charge of Academics and Research, Eye 7 Group of Hospitals, New Delhi
  • Jul 2010 to Jul 2011 – Senior Scientific- Clinical Research Fellow, Glaucoma Sector, Clinique d’ ophthalmologie, Department of Clinical Neurosciences, Glaucoma Sector, Hopitaux Universitaires de Geneve, Switzerland. (Responsibilities including teaching resident doctors and glaucoma fellows)
  • Mar 2007 to Mar 2010 – Senior Research Associate, Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, AIIMS, New Delhi. (Responsibilities including teaching resident doctors)
  • Sept 2003 to Sept 2006 – Senior Registrar, University College of Medical Sciences, and associated Guru Teg Bahadur Hospital, New Delhi. (Responsibilities including teaching resident doctors)

Languages known:

English, Hindi, Urdu, French

Academic, Organisational and Leadership positions:

  • 2024 – Present- Editor in Chief, Ocular Research Journal
  • 2017-to date: Founder, Vision Unlimited, Not for Profit Organization for social responsibility https://vision-unlimited.org/
  • 2019-to date – Editor in Chief –Clinical and Experimental Vision and Eye Research https://www.cleverjournal.org/ https://www.cleverjournal.org/editorial-team/
  • 2016-to date –  Executive Editor – Journal of Current Glaucoma Practice https://www.jocgp.com/journalDetails/JOCGP https://www.jocgp.com/editorialBoard/JOCGP
  • 2019 to Date: Member, Associate Advisory Board, International Society of Glaucoma Surgery
  • 2024 to Date- Member, Program Committee, Bal Raksha Bharat, Save the Children, India
  • 2016 to 2021: Executive Editor-DOS Times
  • 2016-till date: Founder Member, Khem, LGBTQ Rights
  • 2009 to 2016 – Managing Editor – Journal of Current Glaucoma Practice
  • 2023 to date- Member, Delhi Ophthalmic Society International advisory sub-committee
  • 2011 – Founding Secretary – Shamms Ed Deen Alcon Glaucoma Fund, University of Geneva, Switzerland
  • 2013 – Member Scientific Committee – World Glaucoma Congress
  • 2012 – Member Scientific Committee – International Society for Glaucoma Surgery
  • 2010 – Member, Organising Committee – International Society for Glaucoma Surgery
  • Apr 2008 to Dec 2009 – Associate Editor – Delhi Journal of Ophthalmology
  • 2008 – Co-Editor – Proceedings of the Strabismic Panorama
  • 2001 to 2003 – Assistant Editor – Indian Journal of Strabismology and Pediatric Ophthalmology
  • 2007 to 2008 – Deputy Editor – Delhi Journal of Ophthalmology
  • Reviewer for several journals worldwide.

Professional Memberships:

  • International Society of Glaucoma Surgery
  • Glaucoma Society of India
  • Strabismological Society of India
  • All India Ophthalmological Society
  • Delhi Ophthalmological Society
  • Haryana Ophthalmological Society
  • Gurugram Ophthalmological Society
  • American Academy of Ophthalmology
  • Association for Research and Vision in Ophthalmology

Community Ophthalmology Programmes:

  • Responsible for design of skill transfer sessions in glaucoma care, and for screening manuals for glaucoma in Africa and the Middle East. Projected collaboration in execution
  • Skill transfer sessions in advanced glaucoma care in Aswan, Egypt for doctors, residents and optometrists
  • Humanitarian mission to Kom Ombo General Hospital, Aswan, Egypt. Screening program for over 5000 patients, including children for glaucoma in Kom Ombo General Hospital, Aswan, Egypt
  • Management, both medical and surgical, of advanced glaucomas in North Africa
  • Screening for glaucoma and designing and execution of protocols and SOPs for hospital based and community outreach programs, Geneva and Troinnex, Switzerland
  • Screening of UN personnel for glaucoma in an outreach exercise as part of World Glaucoma Week in Geneva, Switzerland
  • Actively involved in the Motiabind Mukti Abhiyan, an outreach program for cataract management in India
  • Execution of eye camps in Sirsa, Haryana, as part of a community sponsored initiative
  • School health and eye care initiatives, Gurugram, Haryana
  • Screening programs for police officers and government officials in Gurugram, Haryana
  • Screening programs for community based screening in Pilibhit, UP and Mewat, Haryana

Design of clinical trials:

  • Population based survey of anterior chamber configuration in North African populations
  • Histochemical correlates of chronic glaucoma medication use on trabecular meshwork and ocular surface
  • Persistency, adherence and compliance to glaucoma medications
  • Selective laser trabeculoplasty as primary therapy in an African population: An efficacy and economics perspective
  • Tear film osmolarity studies in patients on glaucoma therapy
  • Comparative evaluation of sclerothalamotomy ab interno combined with phacoemulsification versus phacoemulsification alone in POAG patients
  • Quantitative versus qualitative control of IOP: A risk benefit analysis
  • 24 hour ambulatory IOP monitoring in angle closure glaucoma
  • Effect of increased intraocular pressure on retinal ganglion cells in chick embryos

Awards

  • Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost. Shibal Bhartiya, Aref A, Shaarawy T. APAO, Hyderabad, India. Best Paper, Glaucoma session
  • Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. Asia Pacific Glaucoma Congress 2012, Bali, Indonesia. Best paper glaucoma session, Top nine most influential papers of the congress
  • Harry Potter and the Ophthalmologists Nemesis: Shibal B., S Khokhar, IV International Congress of Glaucoma Surgery, April 2009, Geneva. Best Poster
  • Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. S.Bhartiya, Jayaprakash V, T Dada, A Panda. DOS Annual Conference, March 2009.Best free paper, glaucoma session.
  • Evaluation of levo-dopa as a therapeutic adjunct to conventional occlusion in amblyopia; Kamlesh, Dadeya S, Shibal F. DOS Midcon, 2001 .Best free paper, squint session.
  • Asia ARVO Young Scientists Travel Grant for the year 2008
  • CSIR Young Scientists Travel Grant for the year 2003,2009
  • World Glaucoma Association Young Scientists Travel Grant for the year 2009, 2013Ju

CV

Published Articles

Publications

Complete List of Publications

Books

Glaucoma Drainage Devices: Springer, Editors: Shibal Bhartiya, Monica Gandhi

Clinical Decision Making in Glaucoma: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Colin Clement, Syril Dorairaj, George Kong, Oscar Albis

Clinical Decision Making in Glaucoma: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Colin Clement, Syril Dorairaj, George Kong, Oscar Albis

ISGS Textbook of Glaucoma surgery. Jaypee Brothers Medical Publishers. Editors: Tarek Shaarawy, Tanuj Dada, Shibal Bhartiya 

Manual of glaucoma: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Parul Icchpujani

Practical Perimetry: Jaypee Brothers Medical Publishers. Editors: Shibal Bhartiya, Murali Ariga. Ronnie George, George V

Living with Glaucoma (e pub Kindle version). Parul Icchpujani, Shibal Bhartiya

Manual of Glaucoma Screening. Jaypee Brothers Medical Publishers (In press)Editors: Shibal Bhartiya,  Tarek Shaarawy

Dutta’s Textbook of Ophthalmology (under compilation) Editor in Chief: Shibal Bhartiya, Editors: Namrata Sharma, Rajiv Raman.

Clinical Handbook of Glaucoma. Editors: Shibal Bhartiya, Maneesh Singh, Arijit Mitra

Master Cases in Glaucoma, Volume 1, Editor: Shibal Bhartiya

Master Cases in Retina (Vol 1) Incessant Nature Science Publishers. Shibal Bhartiya 2024
Clinical Insights into Glaucoma Management. Incessant Nature Science Publishers. Shibal Bhartiya 2024
LMR Ophthalmology: Incessant Nature Science Publishers. Shibal Bhartiya 2024

Video presentations

  1. Complications of trabeculectomy. Tanuj Dada, Shibal Bhartiya, World Glaucoma Congress, Paris 2011.
  2. Sangharsh ek kitanu ke saath: Anita Panda, Shibal Bhartiya et al.67th All India Ophthalmic Society meeting, Jaipur, Feb 2009
  3. AGV in refractory Glaucomas: Surgical caveats. Anita Panda, Shibal Bhartiya et al. AIOS, Jaipur, Feb 2009
  4. Bleb excision and scleral patch graft for hypotony maculopathy. T.Dada, Shibal Bhartiya. DOS Annual Conference, Mar 2009
  5. Nucleus delivery techniques in manual small incision cataract surgery. Panda A,Kumar A ,Bansal R ,Hennig A , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007
  6. Management of anterior capsule rupture in traumatic cataract during phacoemulsification. Mohan S, Panda A, Kumar A , Bansal R , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007

Peer reviewed indexed publications

Dr. Shibal Bhartiya: Expert Glaucoma Specialist & Clinician-Scientist in Gurgaon, is a globally recognized authority in Glaucoma
and Neuro-Ophthalmology. 
With over 27 years of experience, she is one of the few specialists in India who seamlessly bridges the gap between high-volume clinical excellence and international medical research. She is a prolific author of 28 medical textbooks and has
published over 200 peer-reviewed (94 on Pubmed)

research papers in international journals
. Her leadership in the field is
further cemented as the
Executive
Editor of the Journal of Current Glaucoma Practice
and her role on the Associate Advisory Committee of the
International Society of Glaucoma Surgery (ISGS)
Her work can be accessed on Pubmed, Google
Scholar
, ResearchGate
and
ORCID.

 

  1. Bhartiya S, Aggarwal A, Dada R. Bridging Genomics and Practice: Rethinking Genetic Counseling in Glaucoma. J Curr Glaucoma Pract. 2025 Oct-Dec;19(4):155-157. doi: 10.5005/jp-journals-10078-1503. Epub 2025 Dec 15. PMID: 41523176; PMCID: PMC12780359.
  2. Lang MV, Vasu P, Dorairaj EA, Bhartiya S, Dorairaj SK. Glaucoma Risk Reduction as a Secondary Benefit of Glucagon-like Peptide-1 Receptor Agonists: A Review of Emerging Evidence. J Curr Glaucoma Pract. 2025 Oct-Dec;19(4):223-228. doi: 10.5005/jp-journals-10078-1501. Epub 2025 Dec 15. PMID: 41523168; PMCID: PMC12780357.
  3. Bhartiya S, Kong YXG, Ramesh PV, Alam MM, Ambawata M. Evaluating the ease of use and clinical applicability of the Melbourne Rapid Field for visual field testing: A real-world experience. Indian J Ophthalmol. 2026 Jan 1;74(1):117-122. doi: 10.4103/IJO.IJO_1461_25. Epub 2025 Dec 29. PMID: 41460140.
  4. Bhartiya S, Zhang X, Perera S. Minimally Invasive Glaucoma Surgeries, Health Economics, and the Moral Imperative of Equity in Glaucoma Care. J Curr Glaucoma Pract. 2025 Jul-Sep;19(3):103-106. doi: 10.5005/jp-journals-10078-1489. PMID: 41113786; PMCID: PMC12533714.
  5. Bhartiya S, Ichhpujani P, Kapoor S, Parmar UPS, Singh D, Kumar S. Weighted Quality of Life in Glaucoma Patients with Advanced Disease. J Curr Glaucoma Pract. 2025 Apr-Jun;19(2):85-89. doi: 10.5005/jp-journals-10078-1474. Epub 2025 Jul 31. PMID: 41113687; PMCID: PMC12532238.
  6. Bhartiya S, Dorairaj SK. GLP-1 Receptor Agonists, Allostatic Load, and Reframing the Glaucoma Paradigm. J Curr Glaucoma Pract. 2025 Jan-Mar;19(1):1-2. doi: 10.5005/jp-journals-10078-1471. Epub 2025 Mar 24. PMID: 40417146; PMCID: PMC12096885.
  7. Bhartiya S, Ichhpujani P, Wadhwani M. Current perspectives in tackling glaucoma blindness. Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S189-S196. doi: 10.4103/IJO.IJO_3280_23. Epub 2025 Feb 21. PMID: 39982079; PMCID: PMC12013325.
  8. The metabolic shift: Unraveling the potential of ketogenic diet in glaucoma. Bhartiya S. J Curr Glaucoma Pract. 2024 Apr-Jun;18(2):43-44. doi: 10.5005/jp-journals-10078-1435.
  9. Dada T, Mahalingam K, Bhartiya S. Reversing Aging and Improving Health Span in Glaucoma Patients: The Next Frontier? J Curr Glaucoma Pract. 2024 Jul-Sep;18(3):87-93. doi: 10.5005/jp-journals-10078-1451. Epub 2024 Oct 29. PMID: 39575133; PMCID: PMC11576344.
  10. Ocular morbidity profiles of out-of-school children in a North Indian urban slum. Bhartiya S, Wadhwani M, Ichhpujani P, Parmar UPS.Indian J Ophthalmol. 2024 Apr 16. doi: 10.4103/IJO.IJO_622_23. Online ahead of print.PMID: 38622857
  11. Glaucoma Drug Prescription Pattern in North India: Public vs Private Sector Hospitals. Bhartiya S, Ichhpujani P, Parmar UPS, Kapoor S, Kaundal S, Kumar S.J Curr Glaucoma Pract. 2024 Jan-Mar;18(1):16-22. doi: 10.5005/jp-journals-10078-1438.PMID: 38585162
  12. Is GATT the Answer? Bhartiya S, Aktas Z, Ichhpujani P.J Curr Glaucoma Pract. 2023 Oct-Dec;17(4):167-168. doi: 10.5005/jp-journals-10078-1425.PMID: 38269261
  13. Lifestyle Measures for Glaucoma Patients: An Objective Social Media Content Analysis. Chahal R, Jindal A, Parmar UPS, Singh RB, Bhartiya S, Ichhpujani P.J Curr Glaucoma Pract. 2023 Jul-Sep;17(3):141-148. doi: 10.5005/jp-journals-10078-1412.PMID: 37920374
  14. Can We Ever Win with a Suprachoroidal Implant? Au L, Bhartiya S.J Curr Glaucoma Pract. 2023 Apr-Jun;17(2):55-57. doi: 10.5005/jp-journals-10078-1410.PMID: 37485461
  15. New Gonioscopy Technique for Finding Schwalbe’s Line: The Ortiz Maneuver. Albis-Donado O, Ortiz-Arismendi GE, Bhartiya S.J Curr Glaucoma Pract. 2023 Jan-Mar;17(1):37-39. doi: 10.5005/jp-journals-10078-1399.PMID: 37228312
  16. Long-term effect of panretinal photocoagulation on optic nerve head parameters in diabetic retinopathy using Heidelberg retinal tomography III.Wadhwani M, Bhartiya S, Sharma A, Sharma A, Upadhyay AD, Dada T.Oman J Ophthalmol. 2022 Dec 12;16(1):6-11. doi: 10.4103/ojo.OJO_182_2018. eCollection 2023 Jan-Apr.PMID: 37007232
  17. Ocular and Systemic Factors Associated with Glaucoma. Dada T, Verma S, Gagrani M, Bhartiya S, Chauhan N, Satpute K, Sharma N.J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):179-191. doi: 10.5005/jp-journals-10078-1383.PMID: 36793269
  18. Niacinamide and Neuroprotection: The Glaucoma Holy Grail. Bhartiya S.J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):141-143. doi: 10.5005/jp-journals-10078-1390.PMID: 36793265
  19. Bhartiya S. Glaucoma Screening: Is AI the Answer? J Curr Glaucoma Pract. 2022 May-Aug;16(2):71-73. doi: 10.5005/jp-journals-10078-1380. PMID: 36128081; PMCID: PMC9452706.
  20. Bhartiya S, Shaarawy T, Dada T. Editorial. J Curr Glaucoma Pract. 2015 May- Aug;9(2):vii. Epub 2013 Sep 6. PMID: 26997837; PMCID: PMC4750029.
  21. Bhartiya S, Shaarawy T, Dada T. Editorial. J Curr Glaucoma Pract. 2014 May-Aug;8(2):v. Epub 2014 Jun 12. PMID: 26997815; PMCID: PMC4741168.
  22. Bhartiya S. Niacinamide and Neuroprotection: The Glaucoma Holy Grail. J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):141-143. doi: 10.5005/jp-journals-10078-1390. PMID: 36793265; PMCID: PMC9905873.
  23. Bhartiya S. Current Glaucoma Practice: The Covid-19 Impact. J Curr Glaucoma Pract. 2020 Jan-Apr;14(1):1-2. doi: 10.5005/jp-journals-10078-1275. PMID:32581461; PMCID: PMC7302611.
  24. Dada T, Ramesh P, Sethi A, Bhartiya S. Ethics of Glaucoma Widgets. J Curr Glaucoma Pract. 2020 Sep-Dec;14(3):77-80. doi: 10.5005/jp-journals-10078-1288. PMID: 33867754; PMCID: PMC8028034.
  25. Bhartiya S, Ichhpujani P. How to Choose a Mentor? J Curr Glaucoma Pract. 2013 Sep-Dec;7(3):128-9. doi: 10.5005/jp-journals-10008-1150. Epub 2013 Sep 6. PMID: 26997796; PMCID: PMC4741151.
  26. Ichhpujani P, Bhartiya S, Sharma A. Premium IOLs in Glaucoma. J Curr Glaucoma Pract. 2013 May-Aug;7(2):54-7. doi: 10.5005/jp-journals-10008-1138. Epub 2013 May 9. PMID: 26997783; PMCID: PMC4741180.
  27. Bhartiya S. Patient Centricity and the Ethics of Glaucoma Care. J Curr Glaucoma Pract. 2020 May-Aug;14(2):68-71. doi: 10.5005/jp-journals-10078-1281. PMID: 33304063; PMCID: PMC7695931.
  28. Dada T, Mahalingam K, Bhartiya S. Minimally Invasive Glaucoma Surgery-to Remove or Preserve the Trabecular Meshwork: That is the Question? J Curr Glaucoma Pract. 2021 May-Aug;15(2):47-51. doi: 10.5005/jp-journals-10078-1299. PMID: 34720492; PMCID: PMC8543745.
  29. Bhartiya S, Ichhpujani P, Shaarawy T. Surgery on the Trabecular Meshwork: Histopathological Evidence. J Curr Glaucoma Pract. 2015 May-Aug;9(2):51-61. doi: 10.5005/jp-journals-10008-1184. Epub 2015 Sep 25. PMID: 26997835; PMCID: PMC4750027.
  30. Ichhpujani P, Dada T, Bhartiya S. Biodegradable Collagen Implants in Trabeculectomy. J Curr Glaucoma Pract. 2015 Jan-Apr;9(1):24-7. doi: 10.5005/jp-journals-10008-1179. Epub 2015 Jan 15. PMID: 26997829; PMCID: PMC4741144.
  31.  Jha B, Bhartiya S, Sharma R, Arora T, Dada T. Selective Laser Trabeculoplasty: An Overview. J Curr Glaucoma Pract. 2012 May-Aug;6(2):79-90.doi: 10.5005/jp-journals-10008-1111. Epub 2012 Aug 16. PMID: 28028351; PMCID: PMC5161772.
  32. Ichhpujani P, Kalra G, Kaur R, Bhartiya S. Evolution of Glaucoma Research: A Scientometric Review. J Curr Glaucoma Pract. 2020 Sep-Dec;14(3):98-105. doi: 10.5005/jp-journals-10078-1286. PMID: 33867758; PMCID: PMC8028030.
  33. Dhingra D, Bhartiya S. Evaluating glaucoma surgeries in the MIGS context.Rom J Ophthalmol. 2020 Apr-Jun;64(2):85-95. PMID: 32685772; PMCID: PMC7339697.
  34. Current Glaucoma Practice: The Covid-19 Impact Bhartiya S. J Curr Glau Prac 10.5005/jp-journals-10078-1275 (Epub)
  35. 24-hour Intraocular pressure monitoring: the way ahead. Bhartiya S, Gangwani M, Kalra RB, Aggarwal A, Gagrani M, Sirish KN. Rom J Ophthalmol. 2019 Oct-Dec;63(4):315-320.
  36. Long term effect of panretinal photocoagulation on retinal nerve fiber layer parameters in patients with proliferative diabetic retinopathy. Wadhwani M, Bali S, Bhartiya S, Mahabir M, Upadhaya A, Dada T, Sharma A, Mishra SK. Oman J Ophthalmol. 2019 Oct 11;12(3):181-185.
  37. Diurnal Variation of IOP in Angle Closure Disease: Are We Doing Enough? Bhartiya S, Wadhwani M, Rai O, Patuel M, Dorairaj S, Sirish KN. Rom J Ophthalmol. 2019 Jul-Sep;63(3):208-216.
  38. Revisiting Results of Conventional Surgery: Trabeculectomy, Glaucoma Drainage Devices, and Deep Sclerectomy in the Era of MIGS. Bhartiya S, Dhingra D, Shaarawy T. J Curr Glaucoma Pract. 2019 May-Aug;13(2):45-49.
  39. A Novel Mathematical Model of Glaucoma Pathogenesis. Faiq MA, Sidhu T, Sofi RA, Singh HN, Qadri R, Dada R, Bhartiya S, Gagrani M, Dada T. J Curr Glaucoma Pract. 2019 Jan-Apr;13(1):3-8
  40. The Quest for the Holy Grail of Glaucoma Surgery: Does Cypass Herald the End? Bhartiya S, Shaarawy T. J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):99-101.
  41. Citius, Altius, Fortius: Agreement between Perkins and Dynamic Contour Tonometry (Pascal) and the Impact of Altitude. Albis-Donado O, Bhartiya S, Gil-Reyes M, Casale-Vargas G, Arreguin-Rebollar N, Kahook MY.J Curr Glaucoma Pract. 2018 Jan-Apr;12(1):40-44
  42. Bleb needling with subconjunctival ologen insertion using IOL cartridge. Dada T, Angmo D, Bhartiya S, Ramananda K.Oman J Ophthalmol. 2018 Jan-Apr;11(1):94-96.
  43. Assessment of Retinal Nerve Fiber Layer Changes by Cirrus High-definition Optical Coherence Tomography in Myopia.Singh D, K Mishra S, Agarwal E, Sharma R, Bhartiya S, Dada T.J Curr Glaucoma Pract. 2017 May-Aug;11(2):52-57.
  44. In Vivo Confocal Microscopic Characteristics of Crystalline Keratopathy in Patients with Sclerokeratitis.Gupta N, Ganger A, Bhartiya S, Verma M, Tandon R.Ocul Immunol Inflamm. 2017 Feb 22:1-6.
  45.  Evaluation of Physical Properties of Generic and Branded Travoprost Formulations. Wadhwani M, Mishra SK, Angmo D, Velpandian T, Sihota R, Kotnala A, Bhartiya S, Dada T. J Curr Glaucoma Pract. 2016 May-Aug;10(2):49-55.
  46. Editorial.Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2015 Sep-Dec;9(3)
  47.  Editorial.Bhartiya S, Shaarawy T, Dada T.J Curr Glaucoma Pract. 2015 May-Aug;9(2)
  48.  Surgery on the Trabecular Meshwork: Histopathological Evidence.Bhartiya S, Ichhpujani P, Shaarawy T.J Curr Glaucoma Pract. 2015 May-Aug;9(2):51-61.
  49. Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements.Angmo D, Bhartiya S, Mishra SK, Sharma R, Poojari A, Dada T.Nepal J Ophthalmol. 2014 Jul;6(12):185-191.
  50.  Scanning laser polarimetry in glaucoma.Dada T, Sharma R, Angmo D, Sinha G, Bhartiya S, Mishra SK, Panda A, Sihota R.Indian J Ophthalmol. 2014 Nov;62(11):1045-1055..
  51. New perspectives on target intraocular pressure.Clement CI, Bhartiya S, Shaarawy T.Surv Ophthalmol. 2014 Nov-Dec;59(6):615-26.
  52. Novel occurrence of axenfeld: Rieger syndrome in a patient with blepharophimosis ptosis epicanthus inversus syndrome.Shah BM, Dada T, Panda A, Tanwar M, Bhartiya S, Dada R. Indian J Ophthalmol. 2014 Mar;62(3):358-60.
  53. Novel occurrence of axenfeld: Rieger syndrome in a patient with blepharophimosis ptosis epicanthus inversus syndrome.Shah BM, Dada T, Panda A, Tanwar M, Bhartiya S, Dada R. Indian J Ophthalmol. 2014 Mar;62(3):358-65
  54. Complementary and Alternate Management of Glaucoma: The Verdict so Far Shibal Bhartiya, Parul Ichhpujani. Journal of Current Glaucoma Practice. Journal of Current Glaucoma Practice. Amy – Aug 2014; 54-57
  55. How to Choose a Mentor? Shibal Bhartiya, Parul Ichhpujani. Journal of Current Glaucoma Practice. Journal of Current Glaucoma Practice. Sept-Dec 2013; 128-129
  56. Editorial.Bhartiya S, Shaarawy T, Dada T. J Curr Glaucoma Pract. 2014 Jan-Apr;8(1):v.
  57. Editorial.Bhartiya S, Shaarawy T, Dada T.J Curr Glaucoma Pract. 2014 May-Aug;8(2):v
  58. Editorial.Bhartiya S, Shaarawy T, Dada T. J Curr Glaucoma Pract. 2015 Jan-Apr;9(1):vii
  59. Editorial. Bhartiya S, Shaarawy T, Dada T. J Curr Glaucoma Pract. 2015 May-Aug;9(2):vii.
  60. Editorial.Bhartiya S, Shaarawy T, Dada T.J Curr Glaucoma Pract. 2013 Sep-Dec;7(3):vii
  61. Editorial.Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2013 May-Aug;7(2):vii.
  62. Editorial. Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2013 Jan-Apr;7(1):v.
  63. Editorial.Bhartiya Shaarawy T, Dada T S.J Curr Glaucoma Pract. 2012 Sep-Dec;6(3):v
  64. Cataract Surgery in Eyes with Previous Glaucoma Surgery: Pearls and Pitfalls Tanuj Dada, Shibal Bhartiya, Nafees Begum Baig. Journal of Current Glaucoma Practice. Sept-Dec 2013; 99-105
  65. Evaluation of the Van Herick Technique for Screening for Occludable Angles in an African Population Shibal Bhartiya, Tarek Shaarawy. Journal of Current Glaucoma Practice. May- Aug 2013; 88-90
  66. Premium IOLs in Glaucoma Parul Ichhpujani, Shibal Bhartiya, Anuj Sharma Journal of Current Glaucoma Practice. May- Aug 2013; 54-57
  67. Role of Lens Extraction in Primary Angle Closure Disease. Anubha Rathi, Reetika Sharma, Bhaskar Jha, Shibal Bhartiya, Anita Panda. Journal of Current Glaucoma Practice :January-April 2011, 20-25
  68. Evolution of keratoplasty: from darkness to light.Bhartiya S, Gupta N.J Indian Med Assoc. 2012 Oct;110(10):732-5.
  69. Test retest variability of TonoPen AVIA. Bhartiya S, Bali SJ, James M, Panda A, Dada T.Indian J Ophthalmol. 2013 Mar;61(3):129-31.
  70. Agreement of corneal thickness measurement using slitlamp and ultrasound pachymetry.Agarwal T, Bhartiya S, Dada T, Panda A, Jhanji V, Yu M.Eye Contact Lens. 2012 Jul;38(4):231-3.
  71. Comparative evaluation of Diaton and Goldmann applanation tonometers. Bali SJ, Bhartiya S, Sobti A, Dada T, Panda A. Ophthalmologica. 2012;228(1):42-6. doi: 10.1159/000336047. Ultrasound biomicroscopy in glaucoma.Dada T, Gadia R, Sharma A, Ichhpujani P, Bali SJ, Bhartiya S, Panda A.Surv Ophthalmol. 2011 Sep-Oct;56(5):433-50.
  72. Comparative evaluation of TonoPen AVIA, Goldmann applanation tonometry and non-contact tonometry. Bhartiya S, Bali SJ, Sharma R, Chaturvedi N, Dada T. Int Ophthalmol. 2011 Aug;31(4):297-302.
  73.  Ultrasound biomicroscopic assessment of angle parameters in patients with primary angle closure glaucoma undergoing phacoemulsification.Dada T, Mohan S, Bali SJ, Bhartiya S, Sobti A, Panda A.Eur J Ophthalmol. 2011 Sep-Oct;21(5):559-65.
  74.  Surgical management of glaucoma: evolving paradigms.Sharaawy T, Bhartiya S. Indian J Ophthalmol. 2011 Jan;59 Suppl:S123-30.
  75. Selective Laser Trabeculoplasty: An Overview Jha B, Shibal Bhartiya, Kumar R, Dada T. Journal of Current Glaucoma Practice. 2012; 6: 79-90
  76. Knowledge, Attitudes and Self-care Practices associated with Glaucoma among Hospital Personnel in a Tertiary Care Center in North India. Ichhpujani P, Shibal Bhartiya , Kataria M, Topiwala P. J Current Glau Prac 2012;6:108-112.
  77. The Need to maintain Intraocular Pressure over 24 HoursShibal Bhartiya , Ichhpujani P. J Current Glau Prac 2012;6:120-123.
  78. Patient Communication and the Glaucoma Surgeon. Shibal Bhartiya , Ichhpujani P. J Current Glau Prac 2011;5:1-7.
  79. Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas.Dada T, Bhartiya S, Vanathi M, Panda A. Indian J Ophthalmol. 2010 Sep-Oct;58(5):440-2.
  80.  Fibrin glue in ophthalmology.Panda A, Kumar S, Kumar A, Bansal R, Bhartiya S.Indian J Ophthalmol. 2009 Sep-Oct;57(5):371-9.
  81. Measurement of horizontal deviation in dissociated vertical deviation with a +6-diopter lens occluder.Dadeya S, Kamlesh, Naniwal SK, Fatima S. J Pediatr Ophthalmol Strabismus. 2003 Mar-Apr;40(2):115-6.
  82. Comeoscleral perforation after pterygium excision and intraoperative mitomycin C.Dadeya S, Fatima S.Ophthalmic Surg Lasers Imaging. 2003 Mar-Apr;34(2):146-8.
  83. Preliminary results of intraoperative daunorubicin in strabismus surgery. Dadeya S, Kamlesh, Fatima S. J Pediatr Ophthalmol Strabismus. 2002 Nov-Dec;39(6):340-4.
  84. Intraoperative daunorubicin versus conjunctival autograft in primary pterygium surgery.Dadeya S, Kamlesh, Khurana C, Fatima S.Cornea. 2002 Nov;21(8):766-9
  85. Primary inferior oblique overaction-management by inferior oblique recession. Kamlesh, Dadeya S, Kohli V, Fatima S. Indian J Ophthalmol. 2002 Jun;50(2):97-101.
  86.  A modified hang-back recession technique for horizontal strabismus.Dadeya S, Kamlesh, Fatima S, Bhola R, Joon MK.J Pediatr Ophthalmol Strabismus. 2002 Jul-Aug;39(4):195.
  87. The effect of anisometropia on binocular visual function. Dadeya S, Kamlesh, Shibal F.Indian J Ophthalmol. 2001 Dec;49(4):261-3.
  88. Effect of religious fasting on intra-ocular pressure.Dadeya S, Kamlesh, Shibal F, Khurana C, Khanna A. Eye (Lond). 2002 Jul;16(4):463-5.

Peer reviewed articles

  1. Theatre as a Modality for Socioemotional Learning in Children from Urban Slums: A Case Report from Gurgaon, India. Shibal Bhartiya, RV Gopala Krishna, Emily Dorairaj, IJAIMS- International Journal of Advanced and Integrated Medical Sciences. Sept_DEC 2024 Vol.9 No.3
  2. The Future of Ophthalmology Pedagogy: Embracing Innovation and Artificial Intelligence
    Shibal Bhartiya, P V Ramesh. OCULAR RESEARCH JOURNAL. JUL_DEC_ 2024 Vol.1 No.2
  3. Bhartiya, S., & Singh, T. (2023). A cross-sectional study assessing the effectiveness of hygiene related interventions and education delivered in an afterschool club in urban slums of Gurugram. International Journal Of Community Medicine And Public Health, 10(3), 1172–1177. https://doi.org/10.18203/2394-6040.ijcmph20230635
  4. Efficacy of rinse and treat protocol and its acceptability in patients with dry eye disease. Petteri Ingalsuo, Marju Koski, Anssi Poussu, Shibal Bhartiya, Arijit Mitra, Maneesh Singh, Shailley Jain, Monica Gandhi. Clin Exp Vis Eye Research Vol.6 No.2, Jul- Dec 2023
  5. Pink eye: A rose by any other name. Clin Exp Vis Eye Research Vol.6 No.1, Jan- Jun 2023
  6. Systemic Medications and Glaucoma, Medications that increase the risk of Glaucoma. Shibal Bhartiya Clin Exp Vis Eye Research Vol.5 No.2, Jul- Dec 2022
  7. The Ophthalmologists’ Headache. Shibal Bhartiya Clin Exp Vis Eye Research Vol.5 No.2, Jul- Dec 2022
  8. The Art of Clinical Practice in Ophthalmology. Shibal Bhartiya Oc Res J Jul-Dec 2024 Vol.1 No.1
  9. The Open-access Journal Controversy. Shibal Bhartiya Clin Exp Vis Eye Research Vol. 1, No. 1, Jan-June’ 2018
  10. The COVID-19 Black Swan Shibal Bhartiya Clin Exp Vis Eye Research Vol. 2, No. 1, Jan-June’ 2019
  11. Water drinking test: The second innings scorecard. Shibal Bhartiya, Parul Ichhpujani. Clin Exp Vis Eye Research Vol. 3, No. 1, July-Dec’ 2020
  12. Is it time for Precision Medicine in Glaucoma? Shibal Bhartiya, Deepika Dhingra, Parul Ichhpujani. Clin Exp Vis Eye Research Vol. 3, No. 1, July-Dec’ 2020
  13. Notes from ground zero. Shibal Bhartiya. Clin Exp Vis Eye Research Vol.4 No.1, Jan- Jun 2021
  14. Habitual driving vision in a large urban cohort in Western
    India – factors associated with non-adherence to Indian guidelines. Dr. Shibal Bhartiya, Nishant Kumar, Deepika Dhingra, Meenakshi Wadhwani. Clin Exp Vis Eye Research Vol.4 No.1, Jan- Jun 2021
  15. Online teaching and surgical simulators: Substitute for physical ophthalmology clinical and surgical training. Shibal Bhartiya, Parul Ichhpujani. Clin Exp Vis Eye Research Vol.4 No.2, Jul- Dec 2021
  16. Pilocarpine: The Renaissance Shibal Bhartiya, Parul Ichhpujani. Clin Exp Vis Eye Research Vol.5 No.1, Jul- Dec 2022
  17. Acceptability of a second lockdown in Western India: anniversary of lockdown one Shibal Bhartiya, Nishant Kumar 2630-2636; 2021-05-25
  18. Knowledge, attitude and practice pattern regarding use of masks, in an urban slum in West India Shibal Bhartiya, Nishant Kumar, Meenakshi Wadhwani 303-309; 2021-12-27
  19. Domestic violence and COVID-19: the twin pandemic Shibal Bhartiya, Nishant Kumar 2796-2798; 2021-05-25
  20. Knowledge, attitude and practice towards COVID-19 vaccination acceptance in West India Shibal Bhartiya, Nishant Kumar, Tarundeep Singh, Sathiabalan Murugan, Saranya Rajavel, Meenakshi Wadhwani 1170-1176; 2021-02-24
  21. Antibodies to SARS-CoV2 detectable for less than 50 days in polymerase chain reaction confirmed COVID-19 patients Nishant Kumar, Shibal Bhartiya, Tarundeep Singh 3378-3379; 2020-08-28
  22. Knowledge and attitudes regarding effect of diabetes mellitus on eyes and community-based screening for diabetes, hypertension, and visual impairment in central India- a community-based cross-sectional study Shibal Bhartiya, Tarundeep Singh, Nishant Kumar, Tarundeep Singh, Saranya Rajavel, Sathiabalan Murugan 4580-4587; 2022-11-28
  23. Knowledge, attitudes and practices regarding COVID-19 appropriate behaviour and willingness for vaccination among frontline police personnel in Mumbai, India Shibal Bhartiya, Babasaheb V. Tandale, Shailesh D. Pawar, Meenakshi Wadhwani, Nishant Kumar 2129-2136, 2022-04-27
  24. The COVID 19 Black Swan. Clin Exp Vision Eye Res 15713/ins.clever.38 Jun 2020
  25. Talk to you patient, Doc! Spaeth G, Ichhpujani P, Shibal Bhartiya. Glaucoma Today, BMC Today, March-April 2013; 14-17.
  26. http://bmctoday.net/glaucomatoday/2013/04/article.asp?f=talk-to-your-patient-doc
  27. Practical Tips: IOP assessment with the water drinking test. Clement CI, Shibal Bhartiya. Glaucoma Now – Issue No 1, 2013.
  28. http://glaucomanow.com/media/17315/glaucomanow_issue1_2013_practicaltips.pdf
  29. Treatment of Ocular Hypertension. Shibal Bhartiya, Clement CI. Australian Optometry Pharma, March 2013, 14-15.
  30. http://www.optometrists.asn.au/media/239059/pharma_magazine_-_low-res_for_web.pdf
  31. ICLs: Is it a safe bet? S Chaudhary, Shibal Bhartiya et al.  DOS Times, March 2012
  32. Femtosecond laser cataract surgery: The future is here. S Chaudhary, A Tara, Shibal Bhartiya. DOS Times, Jan 2012
  33. European Ophthalmic Review: Recent advances in the treatment of glaucoma: the need to maintain intra ocular pressure over 24 hours. Shibal Bhartiya, Tarek Shaarawy. 2011
  34.  International Glaucoma Review 12-3, December 2010.Transscleral diode laser cycloablation in patients with good vision by: Keith Barton, Shibal Bhartiya, Fabian Lerner, Paul Palmberg, Tarek Shaarawy, Kuldev Singh, Ravi Thomas
  35. Clinical Evaluation of Optic Nerve Head in Glaucoma Shibal Bhartiya, Ritu Gadia, Harinder Sethi, Anita Panda. Journal of Current Glaucoma Practice, September–December 2010; 4(3): 115-132
  36. Ocular surface squamous neoplasia. Noopur Gupta, Shibal Bhartiya. et al.Kerala Journ of Ophthalmology.Vol XXII. Issue 2, June 2010.
  37. http://ksos.in/ksosjournal/journalsub/Journal_Article_20_328.pdf
  38. Vascular Factors in Glaucoma  Dhawan M, Shibal Bhartiya, Mohan S. Journal of Current Glaucoma Practice, January–April 2010; 4(1): 29-35
  39. The Lens and Angle Closure Kumar G, Ichhpujani P, Shibal Bhartiya, Panda A, Journal of Current Glaucoma Practice, January–April 2010; 4(1): 13-20
  40. Pars Plana Ahmed Glaucoma Valve Implantation Journal of Current Glaucoma Practice, September–December 2009.Vol 3. No 3.35-40 Shibal Bhartiya ,Anita Panda
  41. Steroid induced Glacoma.Kerala Journal of Ophthalmology.Vol XXI,Issue 4, Dec 2009. Tanuj Dada, Soman Nair, Munish Dhawan, Shibal Bhartiya
  42. http://ksos.in/ksosjournal/journalsub/Journal_Article_18_281.pdf
  43. Relative Afferent Pupillary Defect. Sumita Sethi, Mridula Mehta, Shibal Bhartiya, Sonia Bhargav. DOS Times
  44. Phacomorphic glaucoma. Tanuj Dada, Shibal Bhartiya, Mahesh Kumar H.M., Anita Panda. DOS Times.
  45. Phacomorphic Glaucoma: Evolving Management Strategies. Journal of Current Glaucoma Practice, June –August 2008 Shibal Bhartiya ,Tanuj Dada, Harinder S Sethi, Anand Aggarwal, Vivek Dave
  46. Cataract and Coexistent Glaucoma: A Therapeutic Dilemma Journal of Current Glaucoma Practice, September-December 2008;2(3):33-47 Shibal Bhartiya ,Tanuj Dada, Harinder S Sethi, Anand Aggarwal, Vivek Dave
  47. History of IOL surgery .Shibal Bhartiya, Sumita Sethi et al .Delhi Jour of Ophthalmology.July-Aug.2009
  48. History of penetrating keratoplasty. Shibal Bhartiya, Anita P. Delhi Jour of Ophthalmology.Sept-Oct.2009
  49. Tonopen: A critical appraisal. Shibal Bhartiya, Sonia Bhargav, Sumita Sethi.DOS Times.Vol.14,No7.Jan,2009
  50. Target IOP: Tear sheet, DOS Times.Vol.14,No 8.Feb 2009 Shibal Bhartiya
  51. Ocular tuberculosis: current paradigms in diagnosis and management. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology Vol 14,no 7.Mar 2008
  52. Diabetic retinopathy: newer horizons. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol 14,no 7.Mar 2008
  53. Voriconazole: new hope for fungal infections. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol.15,No 8,July 2008
  54. Hyperbaric oxygen therapy. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol.15,No 8,July 2008
  55. Standardized nomenclature for uveitis. Rajpal I, Shibal Bhartiya. Delhi Journal of Ophthalmology, Vol.15,No 8July 2008
  56. Repair of corneal perforations. Shalini M, Aggrawal A, Panda A, Shibal Bhartiya. DOS Times, Vol  14-No.2, Aug 2008
  57. Management of posterior capsular rupture: A vitreoretinal perspective. Rajpal Insaan, Shibal Bhartiya, Venkatesh P. Delhi Journal of Ophthalmology, Vol.15, No 8, July 2008
  58. Journal Abstracts. Thirumalesh, Shibal Bhartiya, Depankur Mahajan. Delhi Journal of Ophthalmology, Vol.15, No 8, July 2008
  59. Delhi: A Travel through time. Shibal Bhartiya, Subhash Dadeya, Strabismic Panorama 2008.
  60. Journal abstracts. Archna Gupta, Shibal Bhartiya, Subhash Dadeya Souvenir, Strabismic Panorama 2008.
  61. Collagen cross linkage: Newer vistas in ophthalmology.Indian Jour Refractive surgery.A Panda,S Mohan, Shibal Bhartiya .2007,Mar-Apr, 19-22.
  62. Journal Abstracts, Delhi Journal of Ophthalmology. Rajpal I, Shibal Bhartiya. Vol.13, no6. 2007
  63. Management of Amblyopia. Shibal Fatima, Das GK .Orissa State Jour of Ophthalmol.2005, 28-29.
  64. Screening for Retinopathy of Prematurity. Das GK, Shibal Fatima. Orissa State Journal of Opthalmolgy.2005, 17-19.
  65. Amblyopia Major Review. Kamlesh, Dedeya S, Shibal Fatima. Indian Journal of Strabismology and Pediatric Ophthalmology. 2001, 1:5-20.
  66. Comparative evaluation of intraoperative daunorubicin and mitomycin-C in strabismus surgery. Dadeya S, Kamlesh, Shibal Fatima, Joon MK, Khurana C. Indian Journal of Strabismology and Pediatric Ophthalmology. 2001, 1:5-20.
  67. A study to evaluate the changes in refractive and corneal status following horizontal muscle surgery. Kamlesh, Dedeya S, Shibal Fatima, Jain S. Indian Journal of Strabismology and Pediatric Ophthalmolgy 2001, 1:25-30.

Abstracts published

    1. Diurnal intraocular pressure fluctuatuations in eyes with glaucoma. Shibal Bhartiya, Icchpujani P. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    2. Knowledge, Attitude And Self-care Practice About Glaucoma In Personnel At Tertiary Healthcare Units. Ichhpujani P, Shibal Bhartiya, Sharma A. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    3. Diurnal intraocular pressure fluctuatuations in eyes with glaucoma. Shibal Bhartiya, Icchpujani P., Singh TD. Asia ARVO, Nov 2013, New Delhi, India
    4. Getting The Eye Drop In Correctly: Child’s Play?? Sharma A, Ichhpujani P, Shibal Bhartiya. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    5. Safety and efficacy of trans-scleral diode laser cyclophotocoagulation (TS- DLCP) in indian eyes with poor vision. Singh K, Shibal Bhartiya. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
    6. Needle Revision of Failed Blebs with Subconjunctival Bevacizumab and 5-Fluorouracil Injection: A Comparative Case Series. Ichhpujani P, Shibal Bhartiya. APGC 2012, Bali
    7. Continuous IOP monitoring in patients with glaucoma and ocular hypertension treated with Tafluprost. Aref A, Shibal Bhartiya, Shaarawy T. European Glaucoma Societ Meeting 2012, Copenhagen
    8. Ease of administration of antiglaucoma medication: monodose versus multidose vials. Shibal Bhartiya, Shaarawy T. World Glaucoma Congress, 2011, Paris
    9. ASOCT Evaluation of the Deep Scleral Trench Technique of Ahmed Glaucoma Valve Implantation. Shaarawy T, Shibal Bhartiya. World Glaucoma Congress, 2011, Paris
    10. Continuous IOP monitoring in glaucoma patients treated with tafluprost. Aref A, Shibal Bhartiya, Shaarawy T. World Glaucoma Congress, 2011, Paris
    11. Evaluation of IOP measurements using Tonopen Avia in central and peripheral part of cornea. S Majumdar, A Sobti, Shibal Bhartiya et al. Asia ARVO, Singapore, January 2011.
    12. Effect of change in posture in intraocular pressure using Tonopen  Avia  Amit Sobti,Saptorshi Majumdar, Raashi Arora, Shibal Bhartiya, Anita Panda and Tanuj Dada . Asia ARVO, Singapore, January 2011
    13. Evaluation of IOP measurements using Tonopen Avia in central and peripheral part of cornea. S Majumdar, A Sobti, Shibal Bhartiya et al. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    14. Effect of posture on IOP using Tonopen Avia. A Sobti, S Majumdar, Shibal Bhartiya et al. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    15. Comparison of Time Domain and Spectral Domain Optical Coherence Tomography in Retinal Nerve Fiber Layer Thickness Measurements. A Sobti, S Majumdar, Shibal Bhartiya et al. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    16. With a little help from my friends: Shibal Bhartiya, T Shaarawy.5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    17. Surgery for the Jedi: Shibal Bhartiya, N V Ricart. T Shaarawy.5th International Congress of Glaucoma Surgery, New Delhi, November 2010
    18. Comparison of Time Domain and Spectral Domain Optical Coherence Tomography in Retinal Nerve Fiber Layer Thickness Measurements. Shibal Bhartiya, M. Kumar, V. Kumar, S. Khanduja, S.K. Mishra, T. Dada. ARVO,Florida, USA 2010
    19. Prevalence of Plateau Iris in Indian Eyes With Primary Angle Closure Glaucoma. G. Kumar, A. Sharma, A. Panda, Shibal Bhartiya, I. Bhatiya, T. Dada. ARVO, Florida, USA 2010.
    20. Corneal Topography Changes After Goldmann Applanation Tonometry. Tushar Agarwal, Shibal Bhartiya, Tanuj Dada, Murugesan Vanathi, Anita Panda .World Cornea Congress, Boston, USA,2010
    21. Hunter’s syndrome and Buphthalmos in a girl : An unusual ophthalmic association Sethi S, Shibal Bhartiya, Mehta M, Chandra M, Ghose S. Congress of European Association for Vision and Eye Research,2009,Slovenia.
    22. Effect of Two Different Macular Birefringence Imaging Protocols Used for Corneal Compensation, on Retinal Nerve Fiber Layer Thickness Parameters Using Scanning Laser Polarimetry With Variable Corneal Compensation (GdxVCC) in Normals and Eyes Having Macular Lesions .V. Dave, T. Dada, A. Aggarwal, J. Ashar, Shibal Bhartiya, A. Panda.ARVO,2009 Florida
    23. Test retest variability of the Tono-pen Avia.T Dada, Shibal Bhartiya, M James, A Panda et al ARVO,2009 Florida,USA
    24. Test retest variability of the cirrus OCT. Shibal Bhartiya, T Dada et al. World Glaucoma Congress, 2009 Boston, USA
    25. Comparitive evaluation of Cirrus and Stratus OCT in evaluation of retinal nerve fibre layer thickness. Shibal Bhartiya, T Dada et al. World Glaucoma Congress, 2009 Boston, USA
    26. Intraocular pressure elevation associated with use of nasal steroids. P. Srilathaa, T Dada. Shibal Bhartiya
    27. Pars Plana AGV implantation Shibal Bhartiya, T Dada et al. World Glaucoma Congress, 2009 Boston, USA.
    28. Test retest variability of the Tono-pen Avia.T Dada, Shibal Bhartiya,M James ,A Panda et al World Glaucoma Congress, 2009 Boston, USA
    29. Effect of Two Different Macular Birefringence Imaging Protocols Used for Corneal Compensation, on Retinal Nerve Fiber Layer Thickness Parameters Using Scanning Laser Polarimetry With Variable Corneal Compensation (GdxVCC) in Normals and Eyes Having Macular Lesions .V. Dave, T. Dada, A. Aggarwal, J. Ashar, Shibal Bhartiya, World Glaucoma Congress, 2009 Boston, USA
    30. Harry Potter and the Ophthalmologists nemesis. Shibal Bhartiya, S Khokhar, International congress of Glaucoma surgery, 2009, Geneva
    31. Harry Potter and the Ophthalmologists Nemesis . Shibal Bhartiya, S Khokhar Asia ARVO Meeting, Hyderabad ,Jan 2009
    32. Test retest variability of the Tono-pen Avia. M James, Shibal Bhartiya, T Dada Asia ARVO Meeting, Hyderabad , Jan 2009
    33. Effect of topical anaesthetic agent on corneal thickness in myopia. Shibal Bhartiya, A Panda et al. 67th All India Ophthalmic Society Meeting , Jaipur, Feb 2009
    34. Demographic profile of epibulbar dermoids in a tertiary care centre, A Panda, S Mohan, A Aggarwal, M Vanathi, Shibal Bhartiya. 66th All India Ophthalmic Society meeting , Bangalore, Feb 2008
    35. Evaluation of angle chamber parameters after cataract extraction in chronic primary angle closure glaucoma .Dada T, A Panda, S Mohan, A Aggarwal, Shibal Bhartiya. 66th All India Ophthalmic Society meeting , Bangalore , Feb 2008
    36. Kamlesh’s technique for inferior oblique recession. Kamlesh, Dedeya S, Shibal Fatima: Clinical and Experimental Ophthalmology. 2002; 445.Presented at the International Congress of ophthalmology,2002 , Sydney
    37. Corneal topographic changes after pterygium surgery. Shibal Fatima, Dadeya S, Kamlesh. Clinical and Experimental Ophthalmology.2002; 246. Presented at the International Congress of ophthalmology, 2002 , Sydney
    38. Changes in refractive status following strabismus surgery. Kamlesh, Dadeya S, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 446. Presented at the International Congress of ophthalmology,2002 , Sydney
    39. Comparative evaluation of intraoperative daunorubicin and mitomycin-C in strabismus surgery. Dadeya S, Kamlesh, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 446. Presented at the International Congress of ophthalmology,2002 , Sydney
    40. Levo-dopa as an adjuvant to conventional occlusion in amblyopia. Kamlesh, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 446. Presented at the International Congress of ophthalmology,2002 , Sydney
    41. Modified hang back muscle recession for exotropia. Kamlesh, Dadeya S, Shibal Fatima. Clinical and Experimental ophthalmology. 2002; 146. Presented at the International Congress of ophthalmology,2002 , Sydney
    42. Knapp’s procedure versus inferior rectus recession in DEP-II, Kamlesh, Dadeya S, Shibal Fatima. Clinical and Experimental Ophthalmolgy.2002, 445. Presented at the International Congress of ophthalmology,2002 ,Sydney
    43. ARVO 2014, Orlando, Florida. “Intraocular pressure (IOP) related pattern in patients with primary angle closure (PAC) and primary angle closure glaucoma (PACG) before and after laser peripheral iridotomy (LPI).”Shibal Bhartiya, Rene Gookeop, Sonya S Zoula.
    44. ARVO 2014, Orlando, Florida. “Citius, Altius, Fortius: agreement between Perkins and Dynamic Contour Tonometry (Pascal) and the impact of altitude” Oscar A Donado, Shibal Bhartiya et al.

Chapters in books

  1. Criteria for surgical success. Shibal Bhartiya, Ivan Goldberg. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  2. Intraocular Pressure Reduction Conundrum: Surgery or Drugs? Shibal Bhartiya, Monica Gandhi, Colin Clement, Parul Ichhpujani, Tarek M Shaarawy. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  3. Newer glaucoma surgical procedures: How and when to choose. Shibal Bhartiya, Parul Ichhpujani ISGS Textbook of Glaucoma Surgery. Shibal Bhartiya, Parul Ichhpujani. Jaypee Brothers Medical Publishers, 2014
  4. Releasable sutures in trabeculectomy. Parul Ichhpujani, Shibal Bhartiya. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  5. Diode laser cyclophotocoagulation. Shibal Bhartiya, Parul Ichhpujani , Dewang Angmo. ISGS Textbook of Glaucoma Surgery. Jaypee Brothers Medical Publishers, 2014
  6. Postoperative management of non-penetrating glaucoma surgeries. Glaucoma. Elsevier 2013
  7. Non-penetrating glaucoma surgeries: mechanism of action. Glaucoma. Elsevier 2013
  8. Spotlight: If primary deep sclerectomy fails. Glaucoma. Elsevier 2013
  9. Crystalens: Surgical Technique. Jaypee’s Video Atlas of Ophthalmic Surgery. Jaypee Brothers Medical Publishers, 2013
  10. ICL Explantation. Jaypee’s Video Atlas of Ophthalmic Surgery. Jaypee Brothers Medical Publishers, 2013
  11. Femtosecond cataract surgery: The surgical technique. Jaypee’s Video Atlas of Ophthalmic Surgery. Jaypee Brothers Medical Publishers, 2013
  12. IOL power calculations. . Postgraduate Ophthalmology, Jaypee brothers, 2011
  13. Corneal Hysteresis. Postgraduate Ophthalmology, Jaypee brothers, 2011
  14. Femtosecond lasers in Ophthalmology. Postgraduate Ophthalmology, Jaypee brothers, 2011
  15. Mastering Phacoemulsification in Difficult Situations, Jaypee Brothers Medical Publishers, 2008, Pg253-67
  16. Phacoemulsification in Hyperopia. Mastering Phacoemulsification In Difficult Situations, Jaypee Brothers Medical Publishers, 2008, Pg100-05
  17. New Investigations in Glaucoma. Instant Clinical Diagnosis In Ophthalmology: Glaucoma.. Pg210-249. Jaypee Brothers Medical Publishers,2008
  18. Lasers In Glaucoma. Instant Clinical Diagnosis In Ophthalmology: Glaucoma. Pg 250-267.Jaypee Brothers Medical Publishers,2008
  19. Evolution of Keratoplasty. Jaypee Brothers Medical Publishers,2008
  20. Diode Laser Cyclophotocoagulation: Video Assisted Skill Transfer, Jaypee Brothers Medical Publishers,2008
  21. Phacomorphic Glaucoma: Evolving Management Strategies Jaypee Brothers Medical Publishers,2009
  22. AGV With Phacoemulsification, Jaypee Brothers Medical Publishers,2009
  23. Phacoemulsification With Trabeculectomy: Single Site, Instant Clinical Diagnosis In Ophthalmology: Jaypee Brothers Medical Publishers,2009.
  24. Phacoemulsification With Trabeculectomy:Two Site, Instant Clinical Diagnosis In Ophthalmology: Jaypee Brothers Medical Publishers,2009
  25. Combined cataract and AGV surgery. Instant Clinical Diagnosis In Ophthalmology: Jaypee Brothers Medical Publishers,2009
  26. Pars Plana AGV Implantation: Surgical Technique, Jaypee Brothers Medical Publishers,2009
  27. MICS With Trabeculectomy, Jaypee Brothers Medical Publishers,2009
  28. Under publication: Pitfalls in the diagnosis of closed-angle glaucoma. Shibal Bhartiya, Parul Ichhpujani, Monica Gandhi, Oscar Albis Donado. Ed: H V Nema. Jaypee Brothers Medical Publishers.

Oral presentations, original research

  1. Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost Shibal Bhartiya, Aref A, Shaarawy T. APAO, 2012, Hyderabad, India
  2. Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. APGC 2012, Bali.
  3. Continuous IOP monitoring in glaucoma patients treated with tafluprost. Aref A, Shibal Bhartiya, Shaarawy T. World Ophthalmology Congress, Abu Dhabi Feb. 2012
  4. SLT In POAG Patients Of Indian Subcontinent Origin. Shibal Bhartiya, T Shaarawy.5th Internatonal congress of Glaucoma Surgery, New Delhi, November 2010
  5. Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. Amit Sobti, Shibal Bhartiya, Mahesh HM Kumar, Ajay Sharma, Sunil K. Mishra, Tanuj Dada.16th  Indian eye Research group Meeting, Hyderabad, Aug 2010.
  6. Evaluation of the Tono-pen Avia and its Comparison with Goldman Applanation and Non Contact tonometers . Shibal Bhartiya, T Dada, M. James, G. Behera, R. Sihota, A. Panda. Asia ARVO Meeting, Hyderabad ,Jan 2009
  7. Fibrin glue: freedom from the vagaries of sutures. S Khokhar, Shibal Bhartiya et al.67th AIOS, Jaipur , Feb 2009
  8. Comparitive evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements. Shibal Bhartiya, Jayaprakash V, T Dada, A Panda.DOS Annual Conference,March 2009.
  9. Tear meniscometry. M Jain, T Dada, Shibal Bhartiya et al.  DOS Annual Conference,March 2009
  10. Dengue:A foe for ophthalmologists Abhiyan K , Shibal Bhartiya, Subrata M et al . 66th All India Ophthalmic Society meeting , Bangalore, Feb, 2008
  11. To evaluate the epidemiology, microbiological profile and surgical outcome in childhood infective keratitis .A Aggarwal, A Panda, Shalini Mohan, M Vanathi, Shibal Bhartiya, R Bansal . 66th All India Ophthalmic Society meeting ,Feb, Bangalore, 2008
  12. OSSN: current paradigms in diagnosis and management. Shibal Bhartiya, Anita Panda. DOS annual conf ,pan ophthalmology live, Mar 2008 ,Delhi
  13. Prevention of IOL extrusion during triple procedure by iris bridge suture. Shibal Bhartiya, R Bansal, P Soni, A Panda  . 66th All India Ophthalmic Society meeting , Bangalore 2008
  14. Levodopa as an adjuvant to conventional occlusion for treatment of amblyopia in children. Kamlesh, Shibal Bhartiya, R Bhola, S Goel, G Goyal. American Academy of Ophthalmology, Nov 2008
  15. Clear corneal tunnel infections following phacomulsification. Shibal Bhartiya, Panda A. Madan Mohan Cornea Society Meeting, April 2007, New Delhi.
  16. Role of antibiotics in irrigating fluids during cataract surgery. Khurana C, Kamlesh, Shibal Bhartiya, Joon MK, Dadeya S. All India Ophthalmological Society meeting, Delhi, Jan, 2003.
  17. A randomized trial comparing intraoperative MMC and daunorubicin after Pterygium excision. Khurana C, Kamlesh, Shibal Bhartiya, Joon MK, Dadeya S.First Seri ARVO Meeting, Singapore, Feb, 2003.
  18. Clear lens extraction and intraocular lens implantation in anisometropic amblyopia. Kamlesh, Dadeya S, Shibal Bhartiya. All India Ophthamological Society meeting, Ahmedabad, Jan, 2002.
  19. A modified non-adjustable hang back muscle recession technique. Kamlesh, Bhola R, Shibal Bhartiya, Dadeya S. All India Ophthalmological Society meeting, Ahmedabad, Jan 2002.
  20. Evaluation of levo-dopa as a therapeutic adjunct to  conventional occlusion in amblyopia; Kamlesh, Dadeya S, Shibal Bhartiya. DOS Midcon, 2001

Video presentations

  1. Complications of trabeculectomy. Tanuj Dada, Shibal Bhartiya, World Glaucoma Congress, Paris 2011.
  2. Sangharsh ek kitanu ke saath: Anita Panda, Shibal Bhartiya et al.67th All India Ophthalmic Society meeting, Jaipur, Feb 2009
  3. AGV in refractory Glaucomas: Surgical caveats. Anita Panda, Shibal Bhartiya et al. AIOS, Jaipur, Feb 2009
  4. Bleb excision and scleral patch graft for hypotony maculopathy. Dada, Shibal Bhartiya. DOS Annual Conference, Mar 2009
  5. Nucleus delivery techniques in manual small incision cataract surgery. Panda A,Kumar A ,Bansal R ,Hennig A , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007
  6. Management of anterior capsule rupture in traumatic cataract during phacoemulsification. Mohan S, Panda A, Kumar A , Bansal R , Shibal Bhartiya. European society of cataract and refractive surgery meeting .Sept 2007

Awards

  • Continuous IOP Monitoring In Glaucoma Patients Treated With Tafluprost. Shibal Bhartiya, Aref A, Shaarawy T. APAO, Hyderabad, India. Best Paper, Glaucoma session
  • Diurnal Intraocular Pressure Fluctuation in Eyes with Angle Closure. Shibal Bhartiya, Ichhpujani P. Asia Pacific Glaucoma Congress 2012, Bali, Indonesia. Best paper glaucoma session, Top nine most influential papers of the congress.
  • Harry Potter and the Ophthalmologists Nemesis: Shibal B., S Khokhar, IV International Congress of Glaucoma Surgery, April 2009, Geneva. Best Poster
  • Comparitive evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements.S.Bhartiya, Jayaprakash V, T Dada, A Panda.DOS Annual Conference,March 2009.Best free paper, glaucoma session.
  • Evaluation of levo-dopa as a therapeutic adjunct to  conventional occlusion in  amblyopia; Kamlesh, Dadeya S, Shibal F. DOS Midcon, 2001 .Best free paper, squint session
  • Asia ARVO Young Scientists Travel Grant for the year 2008
  • CSIR Young Scientists Travel Grant for the year 2003,2009
  • World Glaucoma Association Young Scientists Travel Grant for the year 2009, 2013

Invited Faculty for training programs

  1. New Technology for IOP monitoring. Symposium: Glaucoma. Asia ARVO, New Delhi, November, 2013
  2. Optic Disc Documentation. Symposium: Optic Nerve and Glaucoma. Asia ARVO, New Delhi, November, 2013
  3. Late complications of drainage implants. Symposium: Tubes. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
  4. Complications of SLT and ALT treatment. Symposium: Laser Trabeculoplasty for open angle glaucoma. World Glaucoma Congress, July17-July19, 2013, Vancouver, Canada
  5. Guest lecture” If glaucoma is a 24 hour disease, why don’t we consider the 24 hour IOP in the risk management of our glaucoma patients as a routine. Glaucons 2012, Glaucoma society of India Meeting, Coimbatore, India, October 2012.
  6. Guest lecture: “New developments in glaucoma surgery.” WOC, Abu Dhabi, UAE, 2012
  7. Chairperson: “ New therapeutic approach in glaucoma” WOC, Abu Dhabi, UAE, 2012
  8. Trabeculoplasty Revolutionising glaucoma management. ESCRS, 2011, Vienna Austria.
  9. Antifibrotics: Instruction course on Emerging Glaucoma surgery. World Glaucoma Congress, June-July 2011, Paris, France
  10. Non penetrating surgery: tips and pearls: World Glaucoma Congress, June-July 2011, Paris, France
  11. Diurnal Intraocular Pressure Monitoring: Whats new? SOE/AAO meeting, Geneva, Switzerland, June 2011
  12. Guest Lecture: “I will get SLT”. If I had glaucoma Meeting . Geneva, Switzerland. 27 January 2011.
  13. Guest Lecture: “Glaucoma”. Swiss Eye Week, Biel, Switzerland. 21-26 January 2011
  14. Guest Lecture: “Aqueous humor dynamics”. Swiss Eye Week, Biel, Switzerland. 21-26 January 2011
  15. Guest Lecture: SLT: A developing country perspective. 7th Aswan Ophthalmic meeting, Aswan, Egypt. January 2011.
  16. Coordinator: ICGS Film Festival, 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  17. Guest lecture: SLT: The First drop. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  18. Instruction Course: Gonioscopy. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  19. Instruction Course: Anterior Segment Imaging. 5th International Congress of Glaucoma Surgery, New Delhi, November 2010
  20. Guest lecture: SOLA (Joint meeting of European and Lebanese Ophthalmological societies) Oct, 2010; Beirut, Lebanon. Trabeculectomy versus non-penetrating procedures: The debate goes on..
  21. Guest lecture: SOLA (Joint meeting of European and Lebanese Ophthalmological societies) October, 2010; Beirut, Lebanon. Glaucoma drainage devices: Indications, technical pearls & complications
  22. Guest lecture: SOLA (Joint meeting of European and Lebanese Ophthalmological societies) October, 2010; Beirut, Lebanon. New glaucoma surgical procedures that do not rely on the conjunctiva
  23. Guest lecture: Management of Phacomorphic Glaucoma, Russian Glaucoma Society Meeting, December 2009
  24. Judge and moderator: Free paper presentation in cataract and glaucoma, South Asian Association of Ophthalmology, 22-24 Aug,2008

Non Domain Knowledge Publications

Glaucoma Treatment in Gurgaon

Glaucoma Treatment in Gurgaon: Eye drops, Laser and Surgery Explained by Dr Shibal Bhartiya, a fellowship trained glaucoma specialist.

Glaucoma is a chronic disease. It cannot be cured, but it can be controlled. With the right glaucoma treatment, most patients keep their vision for life. Glaucoma treatment is not one-size-fits-all. The right treatment depends on your glaucoma type, your optic nerve health, your age, your lifestyle, and how fast your disease is progressing. The goal is never just to lower a number, it is to protect the optic nerve over the long arc of your life. This page explains all three treatment options: eye drops, laser, and surgery.

It answers the questions patients most commonly ask about each. If you have been recently diagnosed, or if you are reviewing your current treatment plan, this guide will help you understand your options and what to expect.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care.

Dr Bhartiya performs SLT, laser iridotomy, trabeculectomy, MIGS, and Ahmed Glaucoma Valve implantation, and sees patients from across North India for structured second opinions. She is rated 5 stars across 1,500+ patient reviews on Google. If you have questions about your specific situation, a structured consultation or second opinion can bring clarity.

Unlike a general eye clinic, her consultations focus on individualised target pressure setting, long-term disease trajectory, and treatment decisions that account for your age, lifestyle, and rate of progression: not just your last IOP reading

Q1. I have glaucoma. What are my treatment options?

Your doctor will first perform a test called gonioscopy and other diagnostic tests to determine your glaucoma subtype: open angle or closed angle. This guides all treatment decisions. 

For open-angle glaucoma, treatment usually starts with eye drops to lower eye pressure. Your doctor will monitor their effect over time and adjust as needed. A laser procedure called selective laser trabeculoplasty (SLT) may also be offered, either as a first-line treatment or alongside drops.

For closed-angle glaucoma, a laser procedure called laser peripheral iridotomy (LPI) is the first step. It creates an alternative drainage channel in the iris. Eye drops may be added after.

If drops and laser do not achieve adequate pressure control, particularly in advanced glaucoma or complex subtypes, surgery is recommended. Options include trabeculectomy, minimally invasive glaucoma surgery (MIGS), and tube shunt implants such as the Ahmed Glaucoma Valve.

— Eye Drops —

Q2. What are the common glaucoma medications?

The table below lists the most commonly used glaucoma eye drops. This is not an exhaustive list. Your doctor will prescribe what is most appropriate for your eye pressure, general health, and lifestyle, and customise your glaucoma treatment to best preserve your vision long term.

Class

Drug Name

Action

Half-life

Dosage

Brand Names (India)

Prostaglandin Analogues

Latanoprost

Outflow

Long

Once at bedtime

Xalatan, Latoprost RT

 

Travoprost

Outflow

Long

Once at bedtime

Travatan

 

Bimatoprost

Outflow

Long

Once at bedtime

Lumigan

Beta Blockers

Timolol

Inflow

Moderate

Twice daily

Iotim, Glucomol, Timolol GFS

 

Levobunolol

Inflow

Moderate

Twice daily

Betagan

 

Betaxolol

Inflow

Moderate

Twice daily

Betoptic

Alpha Agonists

Brimonidine

Inflow / Outflow

Moderate

Three times daily

Alphagan

Carbonic Anhydrase Inhibitors

Acetazolamide (tablet)

Inflow

Short

Three times daily / SOS

Diamox, Iopar SR

 

Dorzolamide

Inflow

Shorter

Three times daily

Dorzox

 

Brinzolamide

Inflow

Shorter

Twice daily

Azopt

Miotics

Pilocarpine

Outflow

Short

Three times daily

Pilocarpine

Q3. My eye pressure is normal after medication. Do I still need to take my drops?

Yes, always. Your eye pressure is normal because the drops are working. If you stop, the pressure will rise again within days.

Think of glaucoma like high blood pressure or diabetes. Medication controls the condition; it does not cure it. Stopping glaucoma treatment puts your vision at risk.

Important to Understand: What is my target eye pressure?

Target IOP is the pressure level that will keep your specific optic nerve stable over your lifetime. It is not the same for every patient. Someone with early glaucoma and a healthy nerve may have a target of 18 mmHg. Someone with advanced damage may need a target below 12. Your target is set based on your optic nerve, your rate of progression, your age, and your individual risk. It changes over time as new information comes in.

If your glaucoma continues to progress despite drops, laser or surgery may be the next step.

Q4. Can I switch to a generic medicine?

Generic eye drops contain the same active ingredient at the same concentration, and are chemically equivalent to branded products. In most cases, they are appropriate to use.

However, equivalence in eye drops is harder to guarantee than with tablets, because blood levels cannot be monitored. Small differences in preservatives, drop size, or packaging can affect how well the drop is absorbed and how comfortable it feels.

Discuss any switch with your doctor. If your eye pressures remain stable and the drop is comfortable, a generic may be a reasonable, cost-effective option for glaucoma treatment.

Q5. What are the side effects of glaucoma eye drops?

Patients often ask me about Glaucoma Eye Drop Side Effects: What to Expect? Almost all glaucoma drops can cause some eye dryness or local irritation. Allergic reactions are possible with any medication. Specific side effects by drug class include:

  • Prostaglandin Analogues: Darkening of iris or eyelid skin (especially with light eyes), redness, stinging, blurred vision, growth of eyelashes.
  • Beta Blockers: Slowed pulse, fatigue, shortness of breath (particularly in asthma patients), reduced libido, low mood.
  • Alpha Agonists: Stinging, fatigue, headache, drowsiness, dry mouth and nose.
  • Carbonic Anhydrase Inhibitors (eye drop): Stinging, altered taste.
  • Carbonic Anhydrase Inhibitors (oral tablet): Tingling in hands and feet, stomach upset, confusion, low mood, metabolic imbalances.

Note: Preservative Free Glaucoma Eye drops

Most standard glaucoma drops contain a preservative called BAK (benzalkonium chloride). BAK keeps the bottle sterile, but it also irritates the surface of the eye. Used daily for years, it can cause chronic dry eye, redness, and a condition called ocular surface disease.

This matters more than most patients realise. If your eyes are constantly irritated, you are less likely to use your drops consistently. And inconsistent drops mean uncontrolled pressure.

Preservative-free formulations of most common glaucoma medications now exist, including prostaglandins, beta blockers, and fixed combinations. They cost more, but for patients on long-term treatment, or those already prone to dry eye, they are often the right choice.

If your eyes feel persistently dry, red, or irritated on your current drops, tell your doctor. It may not be the medication itself, it may be the preservative. Switching formulation is a simple change that can make a significant difference to both comfort and adherence.

📌 Always tell your doctor if you experience new symptoms. Many side effects can be managed by switching to a different class of drop. A second opinion may help if you are struggling.

Q6. How do I put in my eye drops correctly?

Follow your doctor’s instructions on dose and timing. These steps help ensure the drop reaches the eye and stays in:

  1. Wash your hands before you begin.
  2. Tilt your head back while seated, or lie down.
  3. Gently pull your lower lid down with one finger to form a small pocket.
  4. Look up and squeeze one drop into the pocket. Avoid touching the dropper tip to your eye or hand.
  5. Close your eyes for two minutes. Press gently on the inner corner of the closed eye with your fingertip, this reduces absorption into the bloodstream.
  6. If you use more than one type of drop, wait five minutes between each.
  7. Blot any excess from around the eye with a clean tissue.

📌 If your hands shake, rest your hand against your face and approach from the side. If arthritis makes squeezing difficult, ask your doctor about a bottle-squeezing assistive device.

Q7. I keep forgetting to take my eye drops. What can I do?

You are not alone. Adherence is one of the biggest challenges in glaucoma treatment. Missed drops mean higher pressure and faster disease progression.

Practical strategies that help:

  • Set a recurring alarm on your phone and act on it immediately.
  • Keep your drops on your bedside table and link them to a fixed habit, such as removing your glasses at bedtime. (Note: Xalatan requires refrigeration until opened, after which it can be stored at room temperature.)
  • Download an eye drop reminder app, search ‘eye drop reminder’ on the App Store or Google Play.
  • Ask a family member to remind you, or help you track your drops.
  • Use the same system for scheduling your doctor appointments, a shared calendar or phone reminder works well.

— Laser Treatment —

Q8. I have been advised laser iridotomy. What is that?

A laser peripheral iridotomy (LPI) is used to treat or prevent closed-angle glaucoma. The laser creates a tiny opening in the iris, allowing fluid to flow more freely within the eye and preventing dangerous pressure spikes.

Before the procedure, your doctor will instil drops to make your pupil smaller. A local anaesthetic drop is then applied so you feel no pain. A small lens is placed on your eye to improve visibility, and you are asked to look at a red light while the laser is applied.

Most patients experience mild discomfort, but the procedure is brief. Vision may be blurred for up to three days after. Your doctor will usually prescribe steroid drops for about a week.

Dr Shibal Bhartiya has performed SLT and laser iridotomy in hundreds of patients and integrates laser into the overall treatment strategy based on individual disease profile, not as a reflexive first step.

Q9. I have been advised selective laser trabeculoplasty (SLT). What is that?

SLT is used for open-angle glaucoma. It may be offered as a first option, or in case your glaucoma progresses despite drops. A low-energy laser is applied to the drainage angle of the eye. This stimulates the body’s own immune response to improve fluid outflow and lower eye pressure.

Before the procedure, drops are instilled to constrict the pupil and an eye pressure-lowering agent is given about an hour beforehand. A local anaesthetic drop is applied just before the procedure. You will sit at the laser machine with your face in a chin rest, and a contact lens is placed on the eye, as in a gonioscopy. You may feel a brief twinge or sting as the laser is applied.

Afterwards, you will use anti-inflammatory drops for up to a week. Continue all glaucoma medications as before unless told otherwise. Eye pressure is checked an hour after the procedure and again at one week.

📌 SLT takes one to three months to reach peak effect and may be temporary. Continued follow-up is essential. SLT can often be repeated if the effect wears off.

Not sure whether the surgery recommended for you is the right one? A structured second opinion with Dr Shibal Bhartiya can review your reports and give you clarity

— Surgery —

Q10. What is trabeculectomy? Why might I need it?

Trabeculectomy is the most established glaucoma surgery. It is recommended when eye drops and laser have not adequately controlled your eye pressure, or when glaucoma is advanced at the time of diagnosis.

The surgeon creates a small flap in the white of the eye (sclera) through which fluid can drain out, collecting under the conjunctiva as a small elevation called a bleb. You may be able to see the bleb under your upper eyelid if you look in a mirror.

Trabeculectomy is highly effective in reducing eye pressure, and is the gold standard for surgical glaucoma treatment. It does carry risks, which your doctor will discuss with you before the procedure.

Q11. What is minimally invasive glaucoma surgery (MIGS)?

MIGS is a newer category of glaucoma surgery designed to lower eye pressure with less disruption to the eye than traditional surgery. It is often performed at the same time as cataract surgery.

MIGS procedures include devices such as iStent, Hydrus Microstent, and PRESERFLO MicroShunt. They work by improving drainage through the eye’s natural channels, or by creating a new drainage pathway with less tissue disruption.

MIGS is typically suitable for mild to moderate glaucoma where drops are insufficient or poorly tolerated. It carries a lower risk of complications than trabeculectomy but may produce a more modest pressure reduction.

Dr Shibal Bhartiya offers MIGS as part of a comprehensive glaucoma treatment strategy. If you would like to know whether MIGS is suitable for you, a second opinion consultation can help clarify your options.

Q12. What is an Ahmed Glaucoma Valve?

An Ahmed Glaucoma Valve (AGV) is a small silicone drainage implant placed in the eye to allow fluid to drain to a reservoir under the conjunctiva. It is a type of tube shunt surgery.

Your doctor may also place a small piece of donor sclera (white of the eye) to cover the tube and prevent it from working its way out.

Q13. Why am I getting an Ahmed Valve rather than a trabeculectomy?

Both procedures are proven to be equally effective and safe in the long term. Your doctor will recommend the best option based on your individual history.

An Ahmed Valve is often preferred in the following situations:

  • Previous failed trabeculectomy: a repeat trabeculectomy has a lower chance of success.
  • Certain complex glaucoma subtypes, including inflammatory, neovascular, and post-vitreoretinal surgery glaucomas, or cases with scarred corneas.
  • Your doctor may reserve the Valve as a second-line procedure because of its higher cost.

Q14. What will I feel during surgery?

Surgery sounds frightening. Most patients say the anticipation is far harder than the procedure itself.

Most glaucoma surgeries are performed under local anaesthesia. You will receive an injection around the eye to numb it completely, and an intravenous medication to lower eye pressure before the procedure begins.

You will lie on your back. The area around your eye is cleaned, and a sterile drape is placed over your face. If you feel claustrophobic or are asthmatic, tell your anaesthetist in advance, oxygen can be delivered under the drape.

A small clip keeps the eyelid open so you do not need to worry about blinking. You will see the bright light of the surgical microscope. Your vision will blur as the surgery progresses.

You may feel some pressure or tugging, but surgery is largely painless. Most patients report that the anticipation is worse than the procedure itself. The operation typically takes 45 to 60 minutes. You should be back with family within a couple of hours.

Q15. What is the post glaucoma surgery recovery period like?

Most patients experience a temporary drop in central vision immediately after surgery. This usually recovers within a few weeks. A change in your glasses prescription is common and will be assessed once the eye has stabilised.

Your doctor will see you the day after surgery. You will likely wear an eye patch overnight and have it removed the next morning. Follow-up visits are more frequent in the first few weeks, then become less so as your eye stabilises.

You will be prescribed antibiotic and steroid drops. Some of your glaucoma medications may be continued during the early post-operative period.

Q16. Do I need to restrict activity after surgery?

Gentle walking is encouraged soon after surgery, your doctor will recommend it. For the first week, wear an eye shield at night to protect the eye.

  • Return to desk work: approximately two weeks.
  • Strenuous exercise or weight lifting: avoid for at least one month.
  • Swimming: avoid for at least one month.

📌 Always follow your surgeon’s specific instructions. Recovery timelines can vary depending on the type of surgery and how your eye responds.

Q17. What are the risks of glaucoma surgery?

Your doctor has weighed the risks against the risk of untreated glaucoma progression before recommending surgery. The main risks to be aware of include:

  • Temporary vision drop: Reduced central vision in the early post-operative period due to inflammation, pressure fluctuations, or bleeding. This usually resolves within weeks.
  • Cataract: The risk of cataract development increases after glaucoma surgery, and pre-existing cataract may progress faster.
  • Infection: As with any surgery, there is an increased risk of infection. With trabeculectomy, this risk remains elevated long-term due to the presence of the bleb.
  • Need for additional procedures: A further procedure or surgery may be needed to optimise pressure control.

📌 Knowing the risks allows you to monitor for early signs and report them promptly. Most complications are manageable when caught early.

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.